Skip to main content
SpringerLink
Log in

Rare acquired factor V inhibitors combined with positive lupus anticoagulant that successfully treated by plasmapheresis and prednisone acetate: a typical case report

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Ang AL, Kuperan P, Ng CH, Ng HJ (2009) Acquired factor V inhibitor. A problem-based systematic review. Thromb Haemost 101(5):852–859. https://doi.org/10.1160/th08-11-0767

    Article  CAS  PubMed  Google Scholar 

  2. Park GH, Kim S, Kim MS, Yu YM, Kim GH, Lee JS et al (2019) The association between cephalosporin and hypoprothrombinemia: a systematic review and meta-analysis. Int J Environ Res Public Health 16(20):3937. https://doi.org/10.3390/ijerph16203937

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Cui QY, Shen HS, Wu TQ, Chen HF, Yu ZQ, Wang ZY (2015) Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature. Drug Des Devel Ther 9:2395–2398. https://doi.org/10.2147/dddt.S68682

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sridharan M, Fylling KA, Ashrani AA, Chen D, Marshall AL, Hook CC et al (2018) Clinical and laboratory diagnosis of autoimmune factor V inhibitors: a single institutional experience. Thromb Res 171:14–21. https://doi.org/10.1016/j.thromres.2018.09.044

    Article  CAS  PubMed  Google Scholar 

  5. Olson NJ, Ornstein DL (2017) Factor V inhibitors: a diagnostic and therapeutic challenge. Arch Pathol Lab Med 141(12):1728–1731. https://doi.org/10.5858/arpa.2016-0445-RS

    Article  CAS  PubMed  Google Scholar 

  6. Cohen AJ, Kessler CM (1995) Treatment of inherited coagulation disorders. Am J Med 99(6):675–682. https://doi.org/10.1016/s0002-9343(99)80256-3

    Article  CAS  PubMed  Google Scholar 

  7. Fu YX, Kaufman R, Rudolph AE, Collum SE, Blinder MA (1996) Multimodality therapy of an acquired factor V inhibitor. Am J Hematol 51(4):315–318. https://doi.org/10.1002/(sici)1096-8652(199604)51:4<315::aid-ajh11>3.0.co;2-d

    Article  CAS  PubMed  Google Scholar 

  8. Yamada S, Asakura H (2020) Acquired factor V inhibitor. Rinsho Ketsueki 61(7):791–798. https://doi.org/10.11406/rinketsu.61.791

    Article  PubMed  Google Scholar 

  9. Theron A, Burcheri S, Vacheret F, Hillaire-Buys D, Sauguet P, Schved JF et al (2017) Iatrogenic acquired factor V inhibitors: a case report and review of the French pharmacovigilance database. Thromb Res 157:154–156. https://doi.org/10.1016/j.thromres.2017.06.007

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the patient and her son for their consent to publication.

Funding

This work was supported by the Medical Research Project of Health Commission of Hebei Province in 2022 (grant number 20220084).

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Intensive Care, The Second Hospital of Hebei Medical University, No. 215 Heping West Road, Xinhua District, Shijiazhuang, Hebei, 050000, People’s Republic of China

    Ning Yu, Chao Liu, Wenbin Tian & Ya Liu

  2. Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People’s Republic of China

    Xiaojun Liu

  3. Department of Laboratory Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, People’s Republic of China

    Weihao Li

Authors
  1. Ning Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaojun Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wenbin Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Weihao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ya Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Ning Yu and Ya Liu conceived of the study. Chao Liu and Wenbin Tian contributed to data collection, analysis, and interpretation of the results. Ning Yu wrote the manuscript. All authors approved the final manuscript and consented to publish this manuscript.

Corresponding author

Correspondence to Ya Liu.

Ethics declarations

Ethics statement

This study was approved by Research Ethics Committee of the Second Hospital of Hebei Medical University (2022-P027). Written informed consent was obtained from the individual for the publication.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, N., Liu, X., Liu, C. et al. Rare acquired factor V inhibitors combined with positive lupus anticoagulant that successfully treated by plasmapheresis and prednisone acetate: a typical case report. Ann Hematol 102, 2271–2273 (2023). https://doi.org/10.1007/s00277-023-05244-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05244-z

Search

Navigation